ADAM17-mediated shedding of FcγRIIIA on human NK cells: Identification of the cleavage site and relationship with activation

Journal of Immunology

Volumn 192, Issue 2, 2014, Pages 741-751

  Lajoie, Laurie ^a   Congy Jolivet, Nicolas ^a   Bolzec, Armelle ^a   Gouilleux Gruart, Valérie ^a,b   Sicard, Elodie ^a   Sung, Hsueh Cheng ^a   Peiretti, Frank ^c   Moreau, Thierry ^a   Vié, Henri ^d   Clémenceau, Béatrice ^d   Thibault, Gilles ^a,b  

^a UNIVERSITÉ DE TOURS   (France)

^b UNIVERSITY HOSPITAL OF TOURS   (France)

^c INSERM   (France)

^d UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM10 ENDOPEPTIDASE; ALANINE; BIOLOGICAL MARKER; CD16 ANTIGEN; CD56 ANTIGEN; FC GAMMA RECEPTOR IIIA; L SELECTIN; N ETHYLMALEIMIDE; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG; VALINE;

AMINO ACID SEQUENCE; ARTICLE; CELL ACTIVATION; CELL SURFACE; CLEAVAGE SITE; CONTROLLED STUDY; DEGRANULATION; HUMAN; HUMAN CELL; INTERNALIZATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

ADAM PROTEINS; BINDING SITES; CELLS, CULTURED; HUMANS; KILLER CELLS, NATURAL; PEPTIDES; RECEPTORS, IGG;

EID: 84892699587     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301024     Document Type: Article

References (51)

1. Clémenceau, B., R. Vivien, M. Berthomé, N. Robillard, R. Garand, G. Gallot, S. Vollant, and H. Vié. 2008. Effector memory alphabeta T lymphocytes can express FcgammaRIIIa and mediate antibody-dependent cellular cytotoxicity. J. Immunol. 180: 5327-5334.
2. Harrison, D., J. H. Phillips, and L. L. Lanier. 1991. Involvement of a metalloprotease in spontaneous and phorbol ester-induced release of natural killer cell-associated Fc gamma RIII (CD16-II). J. Immunol. 147: 3459-3465.
3. Borrego, F., A. Lopez-Beltran, J. Peña, and R. Solana. 1994. Downregulation of Fc gamma receptor IIIA alpha (CD16-II) on natural killer cells induced by anti-CD16 mAb is independent of protein tyrosine kinases and protein kinase C. Cell. Immunol. 158: 208-217.
4. Congy-Jolivet, N., A. Bolzec, D. Ternant, M. Ohresser, H. Watier, and G. Thibault. 2008. Fc gamma RIIIa expression is not increased on natural killer cells expressing the Fc gamma RIIIa-158V allotype. Cancer Res. 68: 976-980. (Pubitemid 351272214)
5. Cecchetti, S., F. Spadaro, L. Lugini, F. Podo, and C. Ramoni. 2007. Functional role of phosphatidylcholine-specific phospholipase C in regulating CD16 membrane expression in natural killer cells. Eur. J. Immunol. 37: 2912-2922. (Pubitemid 47578310)
6. Bowles, J. A., S.-Y. Wang, B. K. Link, B. Allan, G. Beuerlein, M.-A. Campbell, D. Marquis, B. Ondek, J. E. Wooldridge, B. J. Smith, et al. 2006. Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab. Blood 108: 2648-2654.
7. Grzywacz, B., N. Kataria, and M. R. Verneris. 2007. CD56(dim)CD16(+) NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases. Leukemia 21: 356-359, author reply 359. (Pubitemid 46158133)
8. Reiss, K., and P. Saftig. 2009. The "a disintegrin and metalloprotease" (ADAM) family of sheddases: physiological and cellular functions. Semin. Cell Dev. Biol. 20: 126-137.
9. Black, R. A., C. T. Rauch, C. J. Kozlosky, J. J. Peschon, J. L. Slack, M. F. Wolfson, B. J. Castner, K. L. Stocking, P. Reddy, S. Srinivasan, et al. 1997. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385: 729-733. (Pubitemid 27098094)
10. Kahn, J., R. H. Ingraham, F. Shirley, G. I. Migaki, and T. K. Kishimoto. 1994. Membrane proximal cleavage of L-selectin: identification of the cleavage site and a 6-kD transmembrane peptide fragment of L-selectin. J. Cell Biol. 125: 461-470. (Pubitemid 24135958)
11. Condon, T. P., S. Flournoy, G. J. Sawyer, B. F. Baker, T. K. Kishimoto, and C. F. Bennett. 2001. ADAM17 but not ADAM10 mediates tumor necrosis factoralpha and L-selectin shedding from leukocyte membranes. Antisense Nucleic Acid Drug Dev. 11: 107-116. (Pubitemid 32378315)
12. Yan, Y., K. Shirakabe, and Z. Werb. 2002. The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J. Cell Biol. 158: 221-226.
13. Walcheck, B., A. H. Herrera, C. St Hill, P. E. Mattila, A. R. Whitney, and F. R. Deleo. 2006. ADAM17 activity during human neutrophil activation and apoptosis. Eur. J. Immunol. 36: 968-976.
14. Middelhoven, P. J., A. Ager, D. Roos, and A. J. Verhoeven. 1997. Involvement of a metalloprotease in the shedding of human neutrophil Fc gammaRIIIB. FEBS Lett. 414: 14-18. (Pubitemid 27380346)
15. Bergin, D. A., E. P. Reeves, P. Meleady, M. Henry, O. J. McElvaney, T. P. Carroll, C. Condron, S. H. Chotirmall, M. Clynes, S. J. O'Neill, and N. G. McElvaney. 2010. α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8. J. Clin. Invest. 120: 4236-4250.
16. Guo, S., M. Peng, Q. Zhao, and W. Zhang. 2012. Role of ADAM10 and ADAM17 in CD16b shedding mediated by different stimulators. Chin. Med. Sci. J. 27: 73-79.
17. Wang, Y., J. Wu, R. Newton, N. S. Bahaie, C. Long, and B. Walcheck. 2013. ADAM17 cleaves CD16b (FcγRIIIb) in human neutrophils. Biochim. Biophys. Acta 1833: 680-685.
18. Romee, R., B. Foley, T. Lenvik, Y. Wang, B. Zhang, D. Ankarlo, X. Luo, S. Cooley, M. Verneris, B. Walcheck, and J. Miller. 2013. NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17). Blood 121: 3599-3608.
19. Ravetch, J. V., and B. Perussia. 1989. Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J. Exp. Med. 170: 481-497. (Pubitemid 19204276)
20. Scallon, B. J., E. Scigliano, V. H. Freedman, M. C. Miedel, Y. C. Pan, J. C. Unkeless, and J. P. Kochan. 1989. A human immunoglobulin G receptor exists in both polypeptide-anchored and phosphatidylinositol-glycan-anchored forms. Proc. Natl. Acad. Sci. USA 86: 5079-5083. (Pubitemid 19182236)
21. Selvaraj, P., W. F. Rosse, R. Silber, and T. A. Springer. 1988. The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal haemoglobinuria. Nature 333: 565-567.
22. Huizinga, T. W., C. E. van der Schoot, C. Jost, R. Klaassen, M. Kleijer, A. E. von dem Borne, D. Roos, and P. A. Tetteroo. 1988. The PI-linked receptor FcRIII is released on stimulation of neutrophils. Nature 333: 667-669.
23. Galon, J., I. Moldovan, A. Galinha, M. A. Provost-Marloie, H. Kaudewitz, S. Roman-Roman, W. H. Fridman, and C. Sautès. 1998. Identification of the cleavage site involved in production of plasma soluble Fc gamma receptor type III (CD16). Eur. J. Immunol. 28: 2101-2107. (Pubitemid 28321293)
24. Avril, T., A. C. Jarousseau, H. Watier, J. Boucraut, P. Le Bouteiller, P. Bardos, and G. Thibault. 1999. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism. J. Immunol. 162: 5902-5909. (Pubitemid 29314944)
25. Dall'Ozzo, S., S. Tartas, G. Paintaud, G. Cartron, P. Colombat, P. Bardos, H. Watier, and G. Thibault. 2004. Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship. Cancer Res. 64: 4664-4669. (Pubitemid 38856941)
26. Cadene, M., and B. T. Chait. 2000. A robust, detergent-friendly method for mass spectrometric analysis of integral membrane proteins. Anal. Chem. 72: 5655-5658.
27. Gabant, G., and M. Cadene. 2008. Mass spectrometry of full-length integral membrane proteins to define functionally relevant structural features. Methods 46: 54-61.
28. Levin, J. I., J. M. Chen, K. Cheung, D. Cole, C. Crago, E. D. Santos, X. Du, G. Khafizova, G. MacEwan, C. Niu, et al. 2003. Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates. Bioorg. Med. Chem. Lett. 13: 2799-2803. (Pubitemid 36851573)
29. Caescu, C. I., G. R. Jeschke, and B. E. Turk. 2009. Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10. Biochem. J. 424: 79-88.
30. Lima, M., M. A. Teixeira, M. L. Queirós, M. Leite, A. H. Santos, B. Justiça, and A. Orfão. 2001. Immunophenotypic characterization of normal blood CD56+lo versus CD56+hi NK-cell subsets and its impact on the understanding of their tissue distribution and functional properties. Blood Cells Mol. Dis. 27: 731-743. (Pubitemid 33022301)
31. Huovila, A.-P. J., A. J. Turner, M. Pelto-Huikko, I. Kärkkä inen, and R. M. Ortiz. 2005. Shedding light on ADAM metalloproteinases. Trends Biochem. Sci. 30: 413-422. (Pubitemid 40942037)
32. Borland, G., G. Murphy, and A. Ager. 1999. Tissue inhibitor of metalloproteinases-3 inhibits shedding of L-selectin from leukocytes. J. Biol. Chem. 274: 2810-2815. (Pubitemid 29075363)
33. Zhang, Y., M. Hegen, J. Xu, J. C. Keith, Jr., G. Jin, X. Du, T. Cummons, B. J. Sheppard, L. Sun, Y. Zhu, et al. 2004. Characterization of (2R, 3S)-2-([[4-(2-butynyloxy)phenyl]sulfonyl]amino)-N,3-dihydroxybutanamide, a potent and selective inhibitor of TNF-alpha converting enzyme. Int. Immunopharmacol. 4: 1845-1857. (Pubitemid 39504825)
34. Bryceson, Y. T., M. E. March, H.-G. Ljunggren, and E. O. Long. 2006. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107: 159-166. (Pubitemid 43053538)
35. Göstring, L., M. T. Chew, A. Orlova, I. Höidén- Guthenberg, A. Wennborg, J. Carlsson, and F. Y. Frejd. 2010. Quantification of internalization of EGFRbinding Affibody molecules: Methodological aspects. Int. J. Oncol. 36: 757-763.
36. Clémenceau, B., N. Congy-Jolivet, G. Gallot, R. Vivien, J. Gaschet, G. Thibault, and H. Vié. 2006. Antibody-dependent cellular cytotoxicity (ADCC) is mediated by genetically modified antigen-specific human T lymphocytes. Blood 107: 4669-4677. (Pubitemid 43882614)
37. Contin, C., V. Pitard, T. Itai, S. Nagata, J.-F. Moreau, and J. Déchanet-Merville. 2003. Membrane-anchored CD40 is processed by the tumor necrosis factoralpha-converting enzyme. Implications for CD40 signaling. J. Biol. Chem. 278: 32801-32809. (Pubitemid 37055721)
38. Yamauchi, A., K. Taga, H. S. Mostowski, and E. T. Bloom. 1996. Target cellinduced apoptosis of interleukin-2-activated human natural killer cells: roles of cell surface molecules and intracellular events. Blood 87: 5127-5135. (Pubitemid 26189853)
39. Gardiner, E. E., J. F. Arthur, M. L. Kahn, M. C. Berndt, and R. K. Andrews. 2004. Regulation of platelet membrane levels of glycoprotein VI by a plateletderived metalloproteinase. Blood 104: 3611-3617. (Pubitemid 39564435)
40. Seals, D. F., and S. A. Courtneidge. 2003. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 17: 7-30. (Pubitemid 36062504)
41. Zheng, Y., P. Saftig, D. Hartmann, and C. Blobel. 2004. Evaluation of the contribution of different ADAMs to tumor necrosis factor alpha (TNFalpha) shedding and of the function of the TNFalpha ectodomain in ensuring selective stimulated shedding by the TNFalpha convertase (TACE/ADAM17). J. Biol. Chem. 279: 42898-42906. (Pubitemid 39372180)
42. Horiuchi, K., S. Le Gall, M. Schulte, T. Yamaguchi, K. Reiss, G. Murphy, Y. Toyama, D. Hartmann, P. Saftig, and C. P. Blobel. 2007. Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx. Mol. Biol. Cell 18: 176-188. (Pubitemid 46066719)
43. Wang, S.-Y., E. Racila, R. P. Taylor, and G. J. Weiner. 2008. NK-cell activation and antibody-dependent cellular cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b component of complement. Blood 111: 1456-1463. (Pubitemid 351213433)
44. Beum, P. V., E. M. Peek, M. A. Lindorfer, F. J. Beurskens, P. J. Engelberts, P. W. H. I. Parren, J. G. J. van de Winkel, and R. P. Taylor. 2011. Loss of CD20 and bound CD20 antibody from opsonized B cells occurs more rapidly because of trogocytosis mediated by Fc receptor-expressing effector cells than direct internalization by the B cells. J. Immunol. 187: 3438-3447.
45. Anfossi, N., P. André, S. Guia, C. S. Falk, S. Roetynck, C. A. Stewart, V. Breso, C. Frassati, D. Reviron, D. Middleton, et al. 2006. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25: 331-342. (Pubitemid 44224147)
46. Fauriat, C., E. O. Long, H.-G. Ljunggren, and Y. T. Bryceson. 2010. Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 115: 2167-2176.
47. Cooper, M. A., T. A. Fehniger, S. C. Turner, K. S. Chen, B. A. Ghaheri, T. Ghayur, W. E. Carson, and M. A. Caligiuri. 2001. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 97: 3146-3151.
48. Kurosaki, T., and J. V. Ravetch. 1989. A single amino acid in the glycosyl phosphatidylinositol attachment domain determines the membrane topology of Fc gamma RIII. Nature 342: 805-807. (Pubitemid 20023814)
49. Ferguson, M. A., and A. F. Williams. 1988. Cell-surface anchoring of proteins via glycosyl-phosphatidylinositol structures. Annu. Rev. Biochem. 57: 285-320.
50. Udenfriend, S., and K. Kodukula. 1995. How glycosylphosphatidylinositolanchored membrane proteins are made. Annu. Rev. Biochem. 64: 563-591.
51. Udenfriend, S., and K. Kodukula. 1995. Prediction of omega site in nascent precursor of glycosylphosphatidylinositol protein. Methods Enzymol. 250: 571-582.